Malaysian Genomics Collaborates with Thai Partners to Supply Its Products and Services

The genomics and biopharmaceutical specialist has made the announcement on a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services.

The Group signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development to produce CAR T-cells for supply to Acquest’s customers. Acquest operates a state-of-the-art clinical laboratory and also the largest privately-owned specialty human cell culturing facility in the country.

On top of that, Malaysian Genomics also signed a supply and collaboration agreement with Salus Holdings Co. Ltd. to supply biopharmaceutical and genomics products and services to its customers. Salus is a specialist in wellness and health screening using science and technology for early disease detection and managing programmes for lifestyle intervention based in Bangkok, Thailand. 

A Letter of Intent was inked between the group with Marine Group Co. Ltd. and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and hair of patients.

The signing ceremony was attended by His Excellency Dato’ Jojie Samuel, Ambassador of Malaysia to Thailand and Encik Mohamed Hafiz Md Shariff, Trade Commissioner of MATRADE Bangkok.

“We are looking forward to a fruitful relationship with our Thai partners, Salus and Acquest. These collaborations are part of our strategy of growing our customer base and increasing our presence overseas through working with business partners who have an established presence in their respective market segments,” Chief Executive Officer of Malaysian Genomics, Encik Sasha Nordin remarked.

“This collaboration is the first step as both parties explore the possibilities of conducting joint R&D that can result in new products and services that can be commercialised. We have a state-of-the-art clinical laboratory in Bangkok and also the largest privately-owned specialty human cell culturing facility in the country,” Dr. Roland Neff, CEO of Acquest said.

“At Salus, we use science and technology to provide services on disease detection, prevention and life-span improvement. This collaboration with Malaysian Genomics will enable us to leverage on their genetics knowledge and expertise to offer more products and services while the strategic cooperation is in keeping with our core value of joint innovation to offer new technologies to our customers,” Mr. Choy Hong Yang, Director of Salus said.

“Skin Doctor, Slim Up and BioCell centres are always striving to provide the latest in skin and aesthetic science and technology for our customers. We look forward to collaborating with Malaysian Genomics and with Salus Healthcare on research and development involving cell regeneration products,” Ms. Songsuda Panich, Founder of Marine Group said.

Previous articleMalaysia Records 3.1% Inflation Rate In Line With Market Expectations – Govt
Next articleBNM Says It Won’t Peg Ringgit Or Impose Capital Controls Despite Fall


Please enter your comment!
Please enter your name here